Increased steady-state mutant huntingtin mrna in huntington’s disease brain

Journal of Huntington's Disease

Volumn 2, Issue 4, 2013, Pages 491-500

  Liu, Wanzhao ^a   Chaurette, Joanna ^a   Pfister, Edith L ^a   Kennington, Lori A ^a   Chase, Kathryn O ^a   Bullock, Jocelyn ^b   Vonsattel, Jean Paul G ^c   Faull, Richard L M ^b   Macdonald, Douglas ^d   DiFiglia, Marian ^e   Zamore, Phillip D ^a   Aronin, Neil ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

HTT mRNA alleles; Huntington s disease; Huntington s disease neuropathology grade; Mrna

Indexed keywords

HTT PROTEIN, HUMAN; MESSENGER RNA; MUTANT PROTEIN; NERVE PROTEIN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; BRAIN; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HTT MRNA ALLELES; HUMAN; HUNTINGTON CHOREA; HUNTINGTON'S DISEASE NEUROPATHOLOGY GRADE; MALE; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEAT; VERY ELDERLY;

HTT MRNA ALLELES; HUNTINGTON'S DISEASE; HUNTINGTON'S DISEASE NEUROPATHOLOGY GRADE; MRNA;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; BRAIN; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MUTANT PROTEINS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84906927221     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-130079     Document Type: Article

References (19)

1. MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, Mac-Farlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF, Bates GP, Baxendale S, Hummerich H, Kirby S, North M, Youngman S, Mott R, Zehetner G, Sedlacek Z, Poustka A, Frischauf A-M, Lehrach H, Buckler AJ, Church D, Doucette-Stamm L, O’DonovanMC, Riba-Ramirez L, Shah M, Stanton VP, Strobel SA, Draths KM, Wales JL, Dervan P, Housman DE, Altherr M, Shiang R, Thompson L, Fielder T, Wasmuth JJ, Tagle D, Valdes J, Elmer L, Allard M, Castilla L, Swaroop M, Blanchard K, Collins FS, Snell R, Holloway T, Gillespie K, Datson N, Shaw D, Harper PS. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72:971-83.
2. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet. 1993;4:387-92.
3. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA. Correlation between the onset age of Huntington’s disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet. 1993;2:1547-9.
4. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet. 1993;4:393-7.
5. Gusella JF, MacDonald ME. Huntington’s disease: CAG genetics expands neurobiology. Curr Opin Neurobiol. 1995;5:656-62.
6. Yan H, Dobbie Z, Gruber SB, Markowitz S, Romans K, Giardiello FM, Kinzler KW, Vogelstein B. Small changes in expression affect predisposition to tumorigenesis. Nat Genet. 2002;30:25-6.
7. Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet. 2004;36:394-9.
8. Gagliardi S, Cova E, Davin A, Guareschi S, Abel K, Alvisi E, Laforenza U, Ghidoni R, Cashman JR, Ceroni M, Cereda C. SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Neurobiol Dis. 2010;39:198-203.
9. Chung DW, Rudnicki DD, Yu L, Margolis RL. A natural antisense transcript at the Huntington’s disease repeat locus regulates HTT expression. Hum Mol Genet. 2011;20:3467-77.
10. Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington’s disease patients. Curr Biol. 2009;19:774-8.
11. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol. 1985;44:559-77.
12. LiuW, Kennington LA, Rosas HD, Hersch S, Cha JH, Zamore PD, Aronin N. Linking SNPs to CAG repeat length in Huntington’s disease patients. Nat Methods. 2008;5:951-3.
13. Germer S, Holland MJ, Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 2000;10:258-66.
14. DiFiglia M, Sena-EstevesM, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK, Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A. 2007;104:17204-9.
15. Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL, Davidson BL. RNA interference improves motor and neuropathological abnormalities in a Huntington’s disease mouse model. Proc Natl Acad Sci U S A. 2005;102:5820-5.
16. Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington’s disease mice. Mol Ther. 2009;17:1053-63.
17. Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS, Hung G, Bennett CF, Cleveland DW. Sustained therapeutic reversal of Huntington’s disease by transient repression of huntingtin synthesis. Neuron. 2012;74:1031-44.
18. Wang YL, Liu WZ, Wada E, Murata M, Wada K, Kanazawa I. Clinico-pathological rescue of a model mouse of Huntington’s disease by siRNA. Neurosci Res. 2005;53:241-9.
19. Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N, DiFiglia M. Expression of normal and mutant huntingtin in the developing brain. J Neurosci. 1996;16:5523-35.